文献速递心脑血管急症重症综合管理与镇静镇痛

重型动脉瘤性蛛网膜下腔出血双通道脑脊液引流(脑室+腰大池)的安全性与附加疗效:EARLYDRAIN试验二次分析

Safety and Additive Efficacy of Dual CSF Drainage (Ventricular + Lumbar) in Severe Aneurysmal Subarachnoid Hemorrhage: A Secondary Analysis of the EARLYDRAIN Trial.
PubMed 文献 · Neurocrit Care · 2026-06-08
一句话结论重型aSAH患者中,EVD基础上加腰大池引流安全,但校正损伤严重度后不独立改善血管痉挛或6个月功能结局。

本文为EARLYDRAIN试验的二次分析,按每日ICU设备记录将254例患者分层,排除入院严重度显著更轻的单纯腰大池引流组(n=43,平均GCS 13.3,p<0.001)后,主要比较同时双通道引流(n=92)与单纯EVD(n=119)。两组入院GCS(p=0.672)与脑室内出血比例(p=0.355)均衡,疑似感染率相似(47.8% vs 44.5%,p=0.631)。多因素分析中引流策略非临床血管痉挛(OR 1.02,p=0.950)、永久分流依赖(OR 0.75,p=0.382)或6个月不良功能结局(mRS 3-6,OR 0.75,p=0.336)的独立预测因子;分流依赖由更高总脑脊液引流量(p<0.001)与年龄独立预测,不良功能结局仅由入院Hunt-Hess分级(p<0.001)与年龄(p<0.001)驱动。作者认为双通道引流安全但不独立改善结局,高引流量预测分流依赖却非功能恢复标志,呈现「容量悖论」,因非预设分析结果属探索性。

要点

  • 重型aSAH中EVD加腰大池引流安全:双通道组与单纯EVD组疑似感染率相似(47.8% vs 44.5%,p=0.631)。
  • 校正年龄、Hunt-Hess分级、改良Fisher分级与总脑脊液引流量后,双通道引流非临床血管痉挛独立预测因子(OR 1.02,p=0.950)。
  • 双通道引流非6个月不良功能结局(mRS 3-6)独立预测因子(OR 0.75,p=0.336),也非永久分流依赖独立预测因子(OR 0.75,p=0.382)。
  • 分流依赖由更高总脑脊液引流量(p<0.001)与年龄独立预测;不良功能结局仅由入院Hunt-Hess分级(p<0.001)与年龄(p<0.001)驱动。
  • 作者认为高流量脑脊液引流预测分流依赖但不标志功能恢复,提出重型脑积水中的「容量悖论」;因非预设分析,结果属探索性。

适用人群与场景

  • EARLYDRAIN试验纳入的重型动脉瘤性蛛网膜下腔出血患者,二次分析按每日ICU设备记录分层。
  • 主要分析人群为同时双通道引流(EVD+腰大池,n=92)与单纯EVD(n=119)患者;单纯腰大池引流组(n=43,平均GCS 13.3,p<0.001)因入院严重度显著更轻被排除出疗效模型。

研究设计与关键结果

  • 研究类型:EARLYDRAIN试验二次分析;样本量254例,主要分析比较双通道引流(n=92)与单纯EVD(n=119)。
  • 两组入院GCS(p=0.672)与脑室内出血比例(p=0.355)均衡;疑似感染率双通道组47.8% vs 单纯EVD组44.5%(p=0.631)。
  • 多因素logistic回归校正年龄、Hunt-Hess分级、改良Fisher分级与总脑脊液引流量后,引流策略(双通道 vs EVD)非临床血管痉挛独立预测因子(OR 1.02,p=0.950)。
  • 引流策略非永久分流依赖独立预测因子(OR 0.75,p=0.382),也非6个月不良功能结局(mRS 3-6)独立预测因子(OR 0.75,p=0.336)。
  • 分流依赖由更高总脑脊液引流量(p<0.001)与年龄独立预测;不良功能结局仅由入院Hunt-Hess分级(p<0.001)与年龄(p<0.001)驱动,总脑脊液引流量无统计学意义(p=0.704)。

证据类型、等级与局限

  • 证据类型:RCT(EARLYDRAIN试验)的二次分析,非预设分析。
  • 局限:作者自述因非预设分析,无法确切确立双通道引流优于单纯脑室引流,结果应视为探索性。

对床旁实践的改变

  • 作者认为在重型aSAH中,EVD基础上加腰大池引流安全,但校正损伤严重度后不独立减轻血管痉挛或改善功能结局。
  • 作者认为高总脑脊液引流量预测分流依赖但不标志功能恢复,提出「容量悖论」。
  • 作者指出因非预设分析,无法确切确立双通道引流优于单纯脑室引流,结果应视为探索性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The EARLYDRAIN trial demonstrated the efficacy of lumbar drainage (LD) in aneurysmal subarachnoid hemorrhage (aSAH) but did not differentiate between patients requiring dual drainage [LD plus external ventricular drainage (EVD)] versus single-catheter management.

OBJECTIVE: The purpose of this study was to investigate the safety and additive efficacy of simultaneous double drainage (EVD + LD) compared with isolated EVD in patients with high-grade aSAH, stratifying by actual device usage.

METHODS: This secondary analysis stratified 254 EARLYDRAIN trial participants on the basis of daily intensive care unit (ICU) device records. To minimize selection bias, the isolated LD cohort (n = 43), characterized by significantly milder admission severity (mean Glasgow Coma Scale (GCS) 13.3, p < 0.001), was excluded from efficacy models. The primary analysis compared simultaneous double drainage (n = 92) vs. isolated EVD (n = 119). Multivariable logistic regression models were adjusted for age, Hunt-Hess grade, modified Fisher grade, and total cerebrospinal fluid (CSF) drainage volume.

RESULTS: Double drainage and isolated EVD groups were well balanced for admission GCS (p = 0.672) and intraventricular hemorrhage prevalence (p = 0.355). Suspected infection rates were similar (47.8% vs. 44.5%, p = 0.631). In multivariable analysis, the drainage strategy (double vs. EVD) was not an independent predictor of clinical vasospasm (OR 1.02, p = 0.950), permanent shunt dependency (OR 0.75, p = 0.382), or unfavorable functional outcome (mRS 3-6) at 6 months (OR 0.75, p = 0.336). Instead, shunt dependency was independently predicted by higher total CSF drainage volume (p < 0.001) and age. Conversely, unfavorable functional outcome was driven exclusively by admission Hunt-Hess grade (p < 0.001) and age (p < 0.001), with total CSF volume showing no significance (p = 0.704).

CONCLUSIONS: In patients with high-grade aSAH, the addition of a lumbar drain to an EVD is safe but does not independently mitigate vasospasm or improve functional outcomes when adjusted for injury severity. High-volume CSF drainage predicts shunt dependency but is not a marker of functional recovery, suggesting a "volume paradox" in severe hydrocephalus. Yet, because this was not a prespecified analysis, it is not possible to definitively establish the superiority of a dual-drainage strategy over ventricular drainage alone. Therefore, these results should be interpreted as exploratory.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Trevisi G, Palermo M, D'Arrigo S, et al. Safety and Additive Efficacy of Dual CSF Drainage (Ventricular + Lumbar) in Severe Aneurysmal Subarachnoid Hemorrhage: A Secondary Analysis of the EARLYDRAIN Trial. Neurocrit Care. 2026. PMID: 42260043. doi:10.1007/s12028-026-02565-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。